These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30022574)

  • 1. A randomised controlled trial of patient information leaflets as a medication counselling aid.
    McNeill R; Chin P; Coberger E; Doogue M
    Intern Med J; 2019 Mar; 49(3):328-332. PubMed ID: 30022574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of patient information leaflet and perceived impact of its use on medication adherence.
    Al Jeraisy M; Alshammari H; Albassam M; Al Aamer K; Abolfotouh MA
    BMC Public Health; 2023 Mar; 23(1):488. PubMed ID: 36918823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preference of patient information leaflets over standard drug monographs by patients prescribed hydrochlorothiazide, nifedipine and enalapril.
    Gossell-Williams M; Bennett O; Dias Y; Foster K; Houston M; Wright K; Fairclough Z
    West Indian Med J; 2012 Jun; 61(3):271-9. PubMed ID: 23155986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of medication-related counselling skills in senior medical students: a checklist-based approach.
    Gupta S; Shaw J
    BMC Med Educ; 2019 Sep; 19(1):335. PubMed ID: 31488168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressed patients' preferences for education about medications by pharmacists in Kuwait.
    Al-Saffar N; Abdulkareem A; Abdulhakeem A; Salah AQ; Heba M
    Patient Educ Couns; 2008 Jul; 72(1):94-101. PubMed ID: 18337052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocebo effects of a simplified package leaflet compared to unstandardised oral information and a standard package leaflet: a pilot randomised controlled trial.
    Prediger B; Meyer E; Büchter R; Mathes T
    Trials; 2019 Jul; 20(1):458. PubMed ID: 31349865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How (not) to inform patients about drug use: use and effects of negations in Dutch patient information leaflets.
    Burgers C; Beukeboom CJ; Sparks L; Diepeveen V
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):137-43. PubMed ID: 25044310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positively Framed Risk Information in Patient Information Leaflets Reduces Side Effect Reporting: A Double-Blind Randomized Controlled Trial.
    Webster RK; Weinman J; Rubin GJ
    Ann Behav Med; 2018 Oct; 52(11):920-929. PubMed ID: 30346496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Positively Framing Side-Effect Risk in Two Different Formats on Side-Effect Expectations, Informed Consent and Credibility: A Randomised Trial of 16- to 75-Year-Olds in England.
    Webster RK; Rubin GJ
    Drug Saf; 2020 Oct; 43(10):1011-1022. PubMed ID: 32557180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised comparison of the effect of three patient information leaflet models on older patients' treatment intentions.
    Whatley S; Mamdani M; Upshur RE
    Br J Gen Pract; 2002 Jun; 52(479):483-4. PubMed ID: 12051214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Vietnamese written and verbal medicine information on Vietnamese-speaking Australians' knowledge and satisfaction.
    Mai A; Aslani P
    Br J Clin Pharmacol; 2007 Oct; 64(4):527-35. PubMed ID: 17610525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PIL for every ill? Patient information leaflets (PILs): a review of past, present and future use.
    Kenny T; Wilson RG; Purves IN; Clark J; Newton LD; Newton DP; Moseley DV
    Fam Pract; 1998 Oct; 15(5):471-9. PubMed ID: 9848435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Written medicines information for South African HIV/AIDS patients: does it enhance understanding of co-trimoxazole therapy?
    Mansoor L; Dowse R
    Health Educ Res; 2007 Feb; 22(1):37-48. PubMed ID: 16763073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The OMACS-PIL study: a randomised controlled trial within the OMACS observational study.
    Culliford L; Brierley R; Clout M; Evans R; Maishman R; Phillips D; Tabusa H; Reeves B; Rogers CA
    Trials; 2019 Dec; 20(1):772. PubMed ID: 31881927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using short information leaflets as recruitment tools did not improve recruitment: a randomized controlled trial.
    Brierley G; Richardson R; Torgerson DJ
    J Clin Epidemiol; 2012 Feb; 65(2):147-54. PubMed ID: 21889304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction.
    Homer D; Nightingale P; Jobanputra P
    Musculoskeletal Care; 2009 Jun; 7(2):78-92. PubMed ID: 18792423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Expectations of Side-Effects for Those Which Are Warned Versus Not Warned About in Patient Information Leaflets.
    Webster RK; Rubin GJ
    Ann Behav Med; 2021 Nov; 55(12):1253-1261. PubMed ID: 33821932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typeface legibility of patient information leaflets intended for community-dwelling seniors.
    Chubaty A; Sadowski CA; Carrie AG
    Age Ageing; 2009 Jul; 38(4):441-7. PubMed ID: 19483246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public.
    Mottram DR; Reed C
    J Clin Pharm Ther; 1997 Apr; 22(2):127-34. PubMed ID: 9373811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication safety curriculum: enhancing skills and changing behaviors.
    Karpa KD; Hom LL; Huffman P; Lehman EB; Chinchilli VM; Haidet P; Leong SL
    BMC Med Educ; 2015 Dec; 15():234. PubMed ID: 26711130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.